🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 15 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/07/2002 | 5,74 | 5,80 | 5,60 | 5,67 | -0,18% | 3,40% | 411.000 |
| 08/07/2002 | 5,60 | 5,74 | 5,58 | 5,68 | +0,89% | 2,86% | 515.200 |
| 05/07/2002 | 5,55 | 5,75 | 5,48 | 5,63 | +3,59% | 4,78% | 171.200 |
| 03/07/2002 | 5,37 | 5,54 | 5,16 | 5,43 | +4,93% | 7,08% | 303.000 |
| 02/07/2002 | 5,65 | 5,65 | 5,13 | 5,18 | -8,49% | 9,29% | 374.200 |
| 01/07/2002 | 5,95 | 6,33 | 5,66 | 5,66 | -8,50% | 11,26% | 400.400 |
| 28/06/2002 | 6,00 | 6,35 | 5,63 | 6,18 | +5,64% | 12,08% | 735.800 |
| 27/06/2002 | 5,69 | 6,05 | 5,63 | 5,85 | +1,74% | 7,39% | 401.800 |
| 26/06/2002 | 5,91 | 5,99 | 5,63 | 5,75 | -3,44% | 6,01% | 418.800 |
| 25/06/2002 | 6,05 | 6,25 | 5,95 | 5,96 | -1,81% | 5,04% | 278.200 |
| 24/06/2002 | 6,21 | 6,41 | 6,05 | 6,07 | -3,04% | 5,80% | 391.000 |
| 21/06/2002 | 6,55 | 6,65 | 6,21 | 6,26 | -4,87% | 6,72% | 308.400 |
| 20/06/2002 | 6,75 | 6,79 | 6,58 | 6,58 | -3,31% | 3,11% | 423.600 |
| 19/06/2002 | 6,96 | 7,00 | 6,75 | 6,80 | -2,51% | 3,59% | 385.800 |
| 18/06/2002 | 6,88 | 7,25 | 6,88 | 6,98 | -1,20% | 5,45% | 153.800 |
| 17/06/2002 | 6,89 | 7,18 | 6,88 | 7,06 | +1,58% | 4,36% | 264.600 |
| 14/06/2002 | 6,75 | 6,97 | 6,65 | 6,95 | +2,89% | 4,74% | 175.200 |
| 13/06/2002 | 6,76 | 6,83 | 6,65 | 6,76 | -0,22% | 2,59% | 159.600 |
| 12/06/2002 | 6,90 | 7,10 | 6,62 | 6,77 | -2,52% | 7,03% | 304.400 |
| 11/06/2002 | 7,35 | 7,35 | 6,85 | 6,95 | -5,51% | 6,74% | 136.800 |
| 10/06/2002 | 7,26 | 7,35 | 7,13 | 7,35 | +1,03% | 3,03% | 141.400 |
| 07/06/2002 | 7,48 | 7,48 | 6,75 | 7,28 | -0,82% | 9,70% | 175.600 |
| 06/06/2002 | 7,43 | 7,49 | 7,33 | 7,34 | -1,74% | 2,22% | 206.400 |
| 05/06/2002 | 7,35 | 7,60 | 7,30 | 7,47 | +0,81% | 4,08% | 173.400 |
| 04/06/2002 | 7,25 | 7,44 | 7,23 | 7,41 | +1,02% | 2,90% | 158.200 |
| 03/06/2002 | 7,75 | 7,85 | 7,22 | 7,33 | -4,25% | 8,19% | 314.400 |
| 31/05/2002 | 7,36 | 7,98 | 7,32 | 7,66 | +4,22% | 8,97% | 339.400 |
| 30/05/2002 | 7,36 | 7,37 | 7,14 | 7,35 | -1,08% | 3,19% | 203.400 |
| 29/05/2002 | 7,48 | 7,50 | 7,17 | 7,43 | -0,34% | 4,41% | 336.600 |
| 28/05/2002 | 7,44 | 7,45 | 7,05 | 7,45 | +1,71% | 5,38% | 168.800 |